ArticleFrontiers in cardiovascular medicine2025
Machine learning-based prediction of 1-year mortality using nutritional and inflammatory factors for type A acute aortic dissection with malperfusion.
Article in Frontiers in cardiovascular medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Exploratory machine learning analysis to characterize angioscopic features associated with atherosclerosis-related aortic dissection: an exploratory single-center angioscopic study.Frontiers in cardiovascular medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Acute aortic dissection is a life-threatening condition, and malperfusion significantly exacerbates the prognosis of patients diagnosed with type A Acute aortic dissection (ATAAD). Current risk assessment tools often fail to consider the impact of nutritional and inflammatory factors, limiting their predictive accuracy. The aim of this study was to develop a machine learning model that integrates nutritional and inflammatory indices to predict 1-year mortality in ATAAD patients with malperfusion. Methods: This retrospective study included 433 ATAAD patients with malperfusion from Henan Provincial Chest Hospital (August 2020 to June 2023). Four machine learning models-logistic regression, XGBoost, random forest, and deep neural network-were developed to predict 1-year mortality using inflammatory and nutritional laboratory values, indices, and other clinical variables. Model training employed stratified 5-fold cross-validation and SMOTE for imbalanced data. The area under the receiver operating characteristic (ROC AUC) and other performance metrics were used to evaluate model efficacy, while SHAP values were computed to interpret feature importance. Results: Among 433 ATAAD patients with malperfusion, the random forest model used inflammatory and nutritional laboratory values to achieve the highest discrimination (AUC = 0.8242, 95% CI 0.7095-0.9219), while the XGBoost model performed best with inflammatory and nutritional indices (AUC = 0.7334, 95% CI 0.6115-0.8488). Calibration curves and Brier scores indicated good agreement between predicted and observed outcomes. Decision curve analysis demonstrated consistent net benefit for random forest and XGBoost models across clinically relevant threshold probabilities. Feature importance and SHAP analyses identified albumin, platelet count, total cholesterol, and C-reactive protein as consistently influential predictors. Conclusion: Nutritional and inflammatory factors significantly contribute to the 1-year mortality risk of ATAAD patients with malperfusion. Machine learning models that incorporate these factors, particularly random forest and XGBoost, can effectively stratify patient risk and support clinical decision-making. These findings underscore the importance of a comprehensive approach to risk assessment that includes metabolic and inflammatory markers to enhance patient outcomes and guide personalized interventions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.